 | • レポートコード：D005-01033 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、122ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、結核診断＆治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。結核診断＆治療の種類別市場規模（臨床検査、核酸検査、マントゥー検査、ラジオグラフィー、薬剤感受性検査）、用途別市場規模（病院、政府機関、個人）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Abbott Laboratories、Eiken Chemical、BD、Akonni Biosystems、Cepheid、Thermo Fisher Scientific、Roche、bioMérieux、Bio-Synth、Epistem、Lupin、Sandoz、GSK、Otsuka Novel Products、Labatec、Hain Lifesciences、Sanofi、QIAGEN、Hologic ・地域別グローバル市場分析 2015年-2020年 ・結核診断＆治療の北米市場（アメリカ、カナダ、メキシコ） ・結核診断＆治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・結核診断＆治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・結核診断＆治療の南米市場（ブラジル、アルゼンチン） ・結核診断＆治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：臨床検査、核酸検査、マントゥー検査、ラジオグラフィー、薬剤感受性検査 ・用途別分析：病院、政府機関、個人 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Tuberculosis Diagnosis and Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Tuberculosis Diagnosis and Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Tuberculosis Diagnosis and Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Tuberculosis Diagnosis and Treatment market has been segmented into:
Laboratory testing
Nucleic acid tests
Mantoux test
Radiography
Drug susceptibility test
By Application, Tuberculosis Diagnosis and Treatment has been segmented into:
Hospitals
Government organizations
Individual
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Tuberculosis Diagnosis and Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Tuberculosis Diagnosis and Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Tuberculosis Diagnosis and Treatment market.
The report offers in-depth assessment of the growth and other aspects of the Tuberculosis Diagnosis and Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Tuberculosis Diagnosis and Treatment Market Share Analysis
Tuberculosis Diagnosis and Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Tuberculosis Diagnosis and Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Tuberculosis Diagnosis and Treatment sales, revenue and market share for each player covered in this report.
The major players covered in Tuberculosis Diagnosis and Treatment are:
Abbott Laboratories
Eiken Chemical
BD
Akonni Biosystems
Cepheid
Thermo Fisher Scientific
Roche
bioMérieux
Bio-Synth
Epistem
Lupin
Sandoz
GSK
Otsuka Novel Products
Labatec
Hain Lifesciences
Sanofi
QIAGEN
Hologic
Table of Contents
1 Tuberculosis Diagnosis and Treatment Market Overview
1.1 Product Overview and Scope of Tuberculosis Diagnosis and Treatment
1.2 Classification of Tuberculosis Diagnosis and Treatment by Type
1.2.1 Global Tuberculosis Diagnosis and Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Tuberculosis Diagnosis and Treatment Revenue Market Share by Type in 2019
1.2.3 Laboratory testing
1.2.4 Nucleic acid tests
1.2.5 Mantoux test
1.2.6 Radiography
1.2.7 Drug susceptibility test
1.3 Global Tuberculosis Diagnosis and Treatment Market by Application
1.3.1 Overview: Global Tuberculosis Diagnosis and Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Government organizations
1.3.4 Individual
1.4 Global Tuberculosis Diagnosis and Treatment Market by Regions
1.4.1 Global Tuberculosis Diagnosis and Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Tuberculosis Diagnosis and Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Tuberculosis Diagnosis and Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Tuberculosis Diagnosis and Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Tuberculosis Diagnosis and Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Tuberculosis Diagnosis and Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Tuberculosis Diagnosis and Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott Laboratories SWOT Analysis
2.1.4 Abbott Laboratories Product and Services
2.1.5 Abbott Laboratories Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Eiken Chemical
2.2.1 Eiken Chemical Details
2.2.2 Eiken Chemical Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Eiken Chemical SWOT Analysis
2.2.4 Eiken Chemical Product and Services
2.2.5 Eiken Chemical Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 BD
2.3.1 BD Details
2.3.2 BD Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 BD SWOT Analysis
2.3.4 BD Product and Services
2.3.5 BD Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Akonni Biosystems
2.4.1 Akonni Biosystems Details
2.4.2 Akonni Biosystems Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Akonni Biosystems SWOT Analysis
2.4.4 Akonni Biosystems Product and Services
2.4.5 Akonni Biosystems Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Cepheid
2.5.1 Cepheid Details
2.5.2 Cepheid Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Cepheid SWOT Analysis
2.5.4 Cepheid Product and Services
2.5.5 Cepheid Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Thermo Fisher Scientific
2.6.1 Thermo Fisher Scientific Details
2.6.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Thermo Fisher Scientific SWOT Analysis
2.6.4 Thermo Fisher Scientific Product and Services
2.6.5 Thermo Fisher Scientific Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 Roche
2.7.1 Roche Details
2.7.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Roche SWOT Analysis
2.7.4 Roche Product and Services
2.7.5 Roche Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 bioMérieux
2.8.1 bioMérieux Details
2.8.2 bioMérieux Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 bioMérieux SWOT Analysis
2.8.4 bioMérieux Product and Services
2.8.5 bioMérieux Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.9 Bio-Synth
2.9.1 Bio-Synth Details
2.9.2 Bio-Synth Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Bio-Synth SWOT Analysis
2.9.4 Bio-Synth Product and Services
2.9.5 Bio-Synth Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.10 Epistem
2.10.1 Epistem Details
2.10.2 Epistem Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Epistem SWOT Analysis
2.10.4 Epistem Product and Services
2.10.5 Epistem Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.11 Lupin
2.11.1 Lupin Details
2.11.2 Lupin Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Lupin SWOT Analysis
2.11.4 Lupin Product and Services
2.11.5 Lupin Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.12 Sandoz
2.12.1 Sandoz Details
2.12.2 Sandoz Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Sandoz SWOT Analysis
2.12.4 Sandoz Product and Services
2.12.5 Sandoz Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.13 GSK
2.13.1 GSK Details
2.13.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 GSK SWOT Analysis
2.13.4 GSK Product and Services
2.13.5 GSK Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.14 Otsuka Novel Products
2.14.1 Otsuka Novel Products Details
2.14.2 Otsuka Novel Products Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Otsuka Novel Products SWOT Analysis
2.14.4 Otsuka Novel Products Product and Services
2.14.5 Otsuka Novel Products Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.15 Labatec
2.15.1 Labatec Details
2.15.2 Labatec Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Labatec SWOT Analysis
2.15.4 Labatec Product and Services
2.15.5 Labatec Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.16 Hain Lifesciences
2.16.1 Hain Lifesciences Details
2.16.2 Hain Lifesciences Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Hain Lifesciences SWOT Analysis
2.16.4 Hain Lifesciences Product and Services
2.16.5 Hain Lifesciences Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.17 Sanofi
2.17.1 Sanofi Details
2.17.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Sanofi SWOT Analysis
2.17.4 Sanofi Product and Services
2.17.5 Sanofi Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.18 QIAGEN
2.18.1 QIAGEN Details
2.18.2 QIAGEN Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 QIAGEN SWOT Analysis
2.18.4 QIAGEN Product and Services
2.18.3 QIAGEN Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.19 Hologic
2.19.1 Hologic Details
2.19.2 Hologic Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Hologic SWOT Analysis
2.19.4 Hologic Product and Services
2.19.5 Hologic Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Tuberculosis Diagnosis and Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Tuberculosis Diagnosis and Treatment Players Market Share
3.2.2 Top 10 Tuberculosis Diagnosis and Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Tuberculosis Diagnosis and Treatment Revenue and Market Share by Regions
4.2 North America Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
5 North America Tuberculosis Diagnosis and Treatment Revenue by Countries
5.1 North America Tuberculosis Diagnosis and Treatment Revenue by Countries (2015-2020)
5.2 USA Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
6 Europe Tuberculosis Diagnosis and Treatment Revenue by Countries
6.1 Europe Tuberculosis Diagnosis and Treatment Revenue by Countries (2015-2020)
6.2 Germany Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
6.4 France Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Tuberculosis Diagnosis and Treatment Revenue by Countries
7.1 Asia-Pacific Tuberculosis Diagnosis and Treatment Revenue by Countries (2015-2020)
7.2 China Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
7.5 India Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
8 South America Tuberculosis Diagnosis and Treatment Revenue by Countries
8.1 South America Tuberculosis Diagnosis and Treatment Revenue by Countries (2015-2020)
8.2 Brazil Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Tuberculosis Diagnosis and Treatment by Countries
9.1 Middle East & Africa Tuberculosis Diagnosis and Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Tuberculosis Diagnosis and Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Tuberculosis Diagnosis and Treatment Market Forecast by Type (2019-2024)
10.3 Laboratory testing Revenue Growth Rate (2015-2025)
10.4 Nucleic acid tests Revenue Growth Rate (2015-2025)
10.5 Mantoux test Revenue Growth Rate (2015-2025)
10.6 Radiography Revenue Growth Rate (2015-2025)
10.7 Drug susceptibility test Revenue Growth Rate (2015-2025)
11 Global Tuberculosis Diagnosis and Treatment Market Segment by Application
11.1 Global Tuberculosis Diagnosis and Treatment Revenue Market Share by Application (2015-2020)
11.2 Tuberculosis Diagnosis and Treatment Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Government organizations Revenue Growth (2015-2020)
11.5 Individual Revenue Growth (2015-2020)
12 Global Tuberculosis Diagnosis and Treatment Market Size Forecast (2021-2025)
12.1 Global Tuberculosis Diagnosis and Treatment Market Size Forecast (2021-2025)
12.2 Global Tuberculosis Diagnosis and Treatment Market Forecast by Regions (2021-2025)
12.3 North America Tuberculosis Diagnosis and Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Tuberculosis Diagnosis and Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Tuberculosis Diagnosis and Treatment Revenue Market Forecast (2021-2025)
12.6 South America Tuberculosis Diagnosis and Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Tuberculosis Diagnosis and Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Tuberculosis Diagnosis and Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Tuberculosis Diagnosis and Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Tuberculosis Diagnosis and Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Tuberculosis Diagnosis and Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Abbott Laboratories Corporate Information, Location and Competitors
Table 6. Abbott Laboratories Tuberculosis Diagnosis and Treatment Major Business
Table 7. Abbott Laboratories Tuberculosis Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)
Table 8. Abbott Laboratories SWOT Analysis
Table 9. Abbott Laboratories Tuberculosis Diagnosis and Treatment Product and Solutions
Table 10. Abbott Laboratories Tuberculosis Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Eiken Chemical Corporate Information, Location and Competitors
Table 12. Eiken Chemical Tuberculosis Diagnosis and Treatment Major Business
Table 13. Eiken Chemical Tuberculosis Diagnosis and Treatment Total Revenue (USD Million) (2018-2019)
Table 14. Eiken Chemical SWOT Analysis
Table 15. Eiken Chemical Tuberculosis Diagnosis and Treatment Product and Solutions
Table 16. Eiken Chemical Tuberculosis Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. BD Corporate Information, Location and Competitors
Table 18. BD Tuberculosis Diagnosis and Treatment Major Business
Table 19. BD Tuberculosis Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)
Table 20. BD SWOT Analysis
Table 21. BD Tuberculosis Diagnosis and Treatment Product and Solutions
Table 22. BD Tuberculosis Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Akonni Biosystems Corporate Information, Location and Competitors
Table 24. Akonni Biosystems Tuberculosis Diagnosis and Treatment Major Business
Table 25. Akonni Biosystems Tuberculosis Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)
Table 26. Akonni Biosystems SWOT Analysis
Table 27. Akonni Biosystems Tuberculosis Diagnosis and Treatment Product and Solutions
Table 28. Akonni Biosystems Tuberculosis Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Cepheid Corporate Information, Location and Competitors
Table 30. Cepheid Tuberculosis Diagnosis and Treatment Major Business
Table 31. Cepheid Tuberculosis Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)
Table 32. Cepheid SWOT Analysis
Table 33. Cepheid Tuberculosis Diagnosis and Treatment Product and Solutions
Table 34. Cepheid Tuberculosis Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 36. Thermo Fisher Scientific Tuberculosis Diagnosis and Treatment Major Business
Table 37. Thermo Fisher Scientific Tuberculosis Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)
Table 38. Thermo Fisher Scientific SWOT Analysis
Table 39. Thermo Fisher Scientific Tuberculosis Diagnosis and Treatment Product and Solutions
Table 40. Thermo Fisher Scientific Tuberculosis Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Roche Corporate Information, Location and Competitors
Table 42. Roche Tuberculosis Diagnosis and Treatment Major Business
Table 43. Roche Tuberculosis Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)
Table 44. Roche SWOT Analysis
Table 45. Roche Tuberculosis Diagnosis and Treatment Product and Solutions
Table 46. Roche Tuberculosis Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. bioMérieux Corporate Information, Location and Competitors
Table 48. bioMérieux Tuberculosis Diagnosis and Treatment Major Business
Table 49. bioMérieux Tuberculosis Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)
Table 50. bioMérieux SWOT Analysis
Table 51. bioMérieux Tuberculosis Diagnosis and Treatment Product and Solutions
Table 52. bioMérieux Tuberculosis Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Bio-Synth Corporate Information, Location and Competitors
Table 54. Bio-Synth Tuberculosis Diagnosis and Treatment Major Business
Table 55. Bio-Synth Tuberculosis Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)
Table 56. Bio-Synth SWOT Analysis
Table 57. Bio-Synth Tuberculosis Diagnosis and Treatment Product and Solutions
Table 58. Bio-Synth Tuberculosis Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Epistem Corporate Information, Location and Competitors
Table 60. Epistem Tuberculosis Diagnosis and Treatment Major Business
Table 61. Epistem Tuberculosis Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)
Table 62. Epistem SWOT Analysis
Table 63. Epistem Tuberculosis Diagnosis and Treatment Product and Solutions
Table 64. Epistem Tuberculosis Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Lupin Corporate Information, Location and Competitors
Table 66. Lupin Tuberculosis Diagnosis and Treatment Major Business
Table 67. Lupin Tuberculosis Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)
Table 68. Lupin SWOT Analysis
Table 69. Lupin Tuberculosis Diagnosis and Treatment Product and Solutions
Table 70. Lupin Tuberculosis Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Sandoz Corporate Information, Location and Competitors
Table 72. Sandoz Tuberculosis Diagnosis and Treatment Major Business
Table 73. Sandoz Tuberculosis Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)
Table 74. Sandoz SWOT Analysis
Table 75. Sandoz Tuberculosis Diagnosis and Treatment Product and Solutions
Table 76. Sandoz Tuberculosis Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. GSK Corporate Information, Location and Competitors
Table 78. GSK Tuberculosis Diagnosis and Treatment Major Business
Table 79. GSK Tuberculosis Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)
Table 80. GSK SWOT Analysis
Table 81. GSK Tuberculosis Diagnosis and Treatment Product and Solutions
Table 82. GSK Tuberculosis Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Otsuka Novel Products Corporate Information, Location and Competitors
Table 84. Otsuka Novel Products Tuberculosis Diagnosis and Treatment Major Business
Table 85. Otsuka Novel Products Tuberculosis Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)
Table 86. Otsuka Novel Products SWOT Analysis
Table 87. Otsuka Novel Products Tuberculosis Diagnosis and Treatment Product and Solutions
Table 88. Otsuka Novel Products Tuberculosis Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Labatec Corporate Information, Location and Competitors
Table 90. Labatec Tuberculosis Diagnosis and Treatment Major Business
Table 91. Labatec Tuberculosis Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)
Table 92. Labatec SWOT Analysis
Table 93. Labatec Tuberculosis Diagnosis and Treatment Product and Solutions
Table 94. Labatec Tuberculosis Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. Hain Lifesciences Corporate Information, Location and Competitors
Table 96. Hain Lifesciences Tuberculosis Diagnosis and Treatment Major Business
Table 97. Hain Lifesciences Tuberculosis Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)
Table 98. Hain Lifesciences SWOT Analysis
Table 99. Hain Lifesciences Tuberculosis Diagnosis and Treatment Product and Solutions
Table 100. Hain Lifesciences Tuberculosis Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. Sanofi Corporate Information, Location and Competitors
Table 102. Sanofi Tuberculosis Diagnosis and Treatment Major Business
Table 103. Sanofi Tuberculosis Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)
Table 104. Sanofi SWOT Analysis
Table 105. Sanofi Tuberculosis Diagnosis and Treatment Product and Solutions
Table 106. Sanofi Tuberculosis Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 107. QIAGEN Tuberculosis Diagnosis and Treatment Type and Application
Table 108. QIAGEN Tuberculosis Diagnosis and Treatment Major Business
Table 109. QIAGEN Tuberculosis Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)
Table 110. QIAGEN SWOT Analysis
Table 111. QIAGEN Tuberculosis Diagnosis and Treatment Product and Solutions
Table 112. QIAGEN Tuberculosis Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 113. Hologic Corporate Information, Location and Competitors
Table 114. Hologic Tuberculosis Diagnosis and Treatment Major Business
Table 115. Hologic Tuberculosis Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)
Table 116. Hologic SWOT Analysis
Table 117. Hologic Tuberculosis Diagnosis and Treatment Product and Solutions
Table 118. Hologic Tuberculosis Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 119. Global Tuberculosis Diagnosis and Treatment Revenue (Million USD) by Players (2015-2020)
Table 120. Global Tuberculosis Diagnosis and Treatment Revenue Share by Players (2015-2020)
Table 121. Global Tuberculosis Diagnosis and Treatment Revenue (Million USD) by Regions (2015-2020)
Table 122. Global Tuberculosis Diagnosis and Treatment Revenue Market Share by Regions (2015-2020)
Table 123. North America Tuberculosis Diagnosis and Treatment Revenue by Countries (2015-2020)
Table 124. North America Tuberculosis Diagnosis and Treatment Revenue Market Share by Countries (2015-2020)
Table 125. Europe Tuberculosis Diagnosis and Treatment Revenue (Million USD) by Countries (2015-2020)
Table 126. Asia-Pacific Tuberculosis Diagnosis and Treatment Revenue (Million USD) by Countries (2015-2020)
Table 127. South America Tuberculosis Diagnosis and Treatment Revenue by Countries (2015-2020)
Table 128. South America Tuberculosis Diagnosis and Treatment Revenue Market Share by Countries (2015-2020)
Table 129. Middle East and Africa Tuberculosis Diagnosis and Treatment Revenue (Million USD) by Countries (2015-2020)
Table 130. Middle East and Africa Tuberculosis Diagnosis and Treatment Revenue Market Share by Countries (2015-2020)
Table 131. Global Tuberculosis Diagnosis and Treatment Revenue (Million USD) by Type (2015-2020)
Table 132. Global Tuberculosis Diagnosis and Treatment Revenue Share by Type (2015-2020)
Table 133. Global Tuberculosis Diagnosis and Treatment Revenue Forecast by Type (2021-2025)
Table 134. Global Tuberculosis Diagnosis and Treatment Revenue by Application (2015-2020)
Table 135. Global Tuberculosis Diagnosis and Treatment Revenue Share by Application (2015-2020)
Table 136. Global Tuberculosis Diagnosis and Treatment Revenue Forecast by Application (2021-2025)
Table 137. Global Tuberculosis Diagnosis and Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Tuberculosis Diagnosis and Treatment Picture
Figure 2. Global Tuberculosis Diagnosis and Treatment Revenue Market Share by Type in 2019
Figure 3. Laboratory testing Picture
Figure 4. Nucleic acid tests Picture
Figure 5. Mantoux test Picture
Figure 6. Radiography Picture
Figure 7. Drug susceptibility test Picture
Figure 8. Tuberculosis Diagnosis and Treatment Revenue Market Share by Application in 2019
Figure 9. Hospitals Picture
Figure 10. Government organizations Picture
Figure 11. Individual Picture
Figure 12. Global Tuberculosis Diagnosis and Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Tuberculosis Diagnosis and Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Tuberculosis Diagnosis and Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Tuberculosis Diagnosis and Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Tuberculosis Diagnosis and Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Tuberculosis Diagnosis and Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Tuberculosis Diagnosis and Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Tuberculosis Diagnosis and Treatment Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Tuberculosis Diagnosis and Treatment Revenue Market Share in 2019
Figure 21. Global Top 10 Players Tuberculosis Diagnosis and Treatment Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Tuberculosis Diagnosis and Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Tuberculosis Diagnosis and Treatment Revenue Market Share by Regions (2015-2020)
Figure 25. Global Tuberculosis Diagnosis and Treatment Revenue Market Share by Regions in 2018
Figure 26. North America Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 27. Europe Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 29. South America Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 31. North America Tuberculosis Diagnosis and Treatment Revenue Market Share by Countries (2015-2020)
Figure 32. North America Tuberculosis Diagnosis and Treatment Revenue Market Share by Countries in 2019
Figure 33. USA Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 34. Canada Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 36. Europe Tuberculosis Diagnosis and Treatment Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Tuberculosis Diagnosis and Treatment Revenue Market Share by Countries in 2019
Figure 38. Germany Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 39. UK Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 40. France Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 41. Russia Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 42. Italy Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Tuberculosis Diagnosis and Treatment Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Tuberculosis Diagnosis and Treatment Revenue Market Share by Countries in 2019
Figure 45. China Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 46. Japan Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 47. Korea Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 48. India Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 50. South America Tuberculosis Diagnosis and Treatment Revenue Market Share by Countries (2015-2020)
Figure 51. South America Tuberculosis Diagnosis and Treatment Revenue Market Share by Countries in 2019
Figure 52. Brazil Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Tuberculosis Diagnosis and Treatment Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Tuberculosis Diagnosis and Treatment Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 57. UAE Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 60. Global Tuberculosis Diagnosis and Treatment Revenue Share by Type (2015-2020)
Figure 61. Global Tuberculosis Diagnosis and Treatment Revenue Share by Type in 2019
Figure 62. Global Tuberculosis Diagnosis and Treatment Market Share Forecast by Type (2021-2025)
Figure 63. Global Laboratory testing Revenue Growth Rate (2015-2020)
Figure 64. Global Nucleic acid tests Revenue Growth Rate (2015-2020)
Figure 65. Global Mantoux test Revenue Growth Rate (2015-2020)
Figure 66. Global Radiography Revenue Growth Rate (2015-2020)
Figure 67. Global Drug susceptibility test Revenue Growth Rate (2015-2020)
Figure 68. Global Tuberculosis Diagnosis and Treatment Revenue Share by Application (2015-2020)
Figure 69. Global Tuberculosis Diagnosis and Treatment Revenue Share by Application in 2019
Figure 70. Global Tuberculosis Diagnosis and Treatment Market Share Forecast by Application (2021-2025)
Figure 71. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 72. Global Government organizations Revenue Growth Rate (2015-2020)
Figure 73. Global Individual Revenue Growth Rate (2015-2020)
Figure 74. Global Tuberculosis Diagnosis and Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Tuberculosis Diagnosis and Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Tuberculosis Diagnosis and Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Tuberculosis Diagnosis and Treatment Revenue Market Forecast (2021-2025)
Figure 78. Europe Tuberculosis Diagnosis and Treatment Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Tuberculosis Diagnosis and Treatment Revenue Market Forecast (2021-2025)
Figure 80. South America Tuberculosis Diagnosis and Treatment Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Tuberculosis Diagnosis and Treatment Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
結核治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Tuberculosis Treatment Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tuberculosis Tre…- 結核ワクチン治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Tuberculosis Vaccine Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tuberculosis V…
- クラミジア診断＆治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Chlamydia Diagnosis and Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Chlamydia D…
- HIV診断および治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global HIV Diagnosis and Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The HIV Diagnosis and…
- 急性虚血性脳卒中診断及び治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Acute Ischemic Stroke Diagnosis and Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.2% in the forecast period of 2020 to 2025 and will expected to reach USD 1225.3 million by 2025, from USD 1080.2 million in …